Strategies for Dodging the Obstacles in CAR T Cell Therapy

Chimeric antigen receptor (CAR) T cell therapy has offered cancer patients a new alternative therapeutic choice in recent years. This novel type of therapy holds tremendous promise for the treatment of various hematologic malignancies including B-cell acute lymphoblastic leukemia (B-ALL) and lymphom...

Descripción completa

Detalles Bibliográficos
Autores principales: Safarzadeh Kozani, Pooria, Safarzadeh Kozani, Pouya, Rahbarizadeh, Fatemeh, Khoshtinat Nikkhoi, Shahryar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047470/
https://www.ncbi.nlm.nih.gov/pubmed/33869011
http://dx.doi.org/10.3389/fonc.2021.627549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047470/
https://www.ncbi.nlm.nih.gov/pubmed/33869011
http://dx.doi.org/10.3389/fonc.2021.627549

Ejemplares similares